Generic Flibanserin buy Ukraine

What is FLIBANSERIN (ADDYI)?

The medical drug FLIBANSERIN (ADDYI) is an innovative agent developed specifically for the correction of sexual disorders in women. This pharmacological product is manufactured in the form of tablets for oral administration, which have a characteristic pink color. It belongs to the group of drugs that affect the central nervous system, in particular the balance of neurotransmitters in the brain. The production of this agent is carried out by leading pharmaceutical companies that guarantee high quality and compliance with international safety standards.

The action of the drug is based on a unique mechanism that distinguishes it from drugs intended for the treatment of erectile dysfunction in men. Instead of increasing blood circulation in the pelvic organs, FLIBANSERIN (ADDYI) works directly with brain receptors responsible for the formation of sexual desire. This allows for the effective restoration of natural desire, which may have decreased due to various physiological or psychological factors. It is important to understand that this medication is not a hormonal drug and does not affect estrogen or testosterone levels in a woman's body.

Before starting therapy, consultation with a qualified doctor is mandatory, as self-treatment can lead to undesirable consequences. The specialist must assess the patient's overall health, take a detailed medical history, and rule out possible contraindications. Each organism is unique, so the individual reaction of the body to taking the tablets can vary significantly. Only after a thorough medical diagnosis can a decision be made on the feasibility of prescribing this specific medicinal product.

What is FLIBANSERIN (ADDYI) prescribed for?

The main and only officially approved indication for the use of FLIBANSERIN (ADDYI) is acquired generalized hypoactive sexual desire disorder in women. This condition is characterized by a persistent absence or significant reduction of interest in intimacy, which causes marked emotional distress. The diagnosis is established only when the decrease in libido is not the result of coexisting medical conditions, psychiatric disorders, or relationship problems with the partner. The drug helps restore the balance of chemical substances in the brain, thereby returning the woman's ability to experience sexual desire.

It is worth noting that FLIBANSERIN (ADDYI) is intended exclusively for women in the premenopausal period. The use of this medication is not recommended for the treatment of sexual dysfunction in postmenopausal women, as the efficacy and safety for this group of patients have not been sufficiently studied. Also, the agent is not intended to increase sexual activity in healthy women who do not have a corresponding clinical diagnosis. Its action is aimed precisely at correcting a pathological decrease in libido, rather than artificial stimulation.

Furthermore, FLIBANSERIN (ADDYI) is categorically not used for the treatment of men or children, as its pharmacological profile is adapted exclusively to female physiology. The drug is not capable of solving problems related to physical discomfort during sexual intercourse, such as vaginal dryness or pain. If the decrease in sexual desire is caused by taking other medications, such as antidepressants, the doctor should consider alternative treatment methods. Correct diagnosis is a key factor in achieving the desired therapeutic effect.

Composition and active components of FLIBANSERIN (ADDYI)

The main active substance of the drug is flibanserin itself, which acts as an agonist and antagonist of serotonin receptors. This active compound is capable of specifically binding to certain receptors in the central nervous system, modulating their activity. Due to this influence, a complex biochemical reaction occurs, which leads to a change in the concentration of key neurotransmitters in the prefrontal cortex of the brain. This area is responsible for control over human emotions, motivation, and sexual impulses.

The composition of FLIBANSERIN (ADDYI) tablets also includes various auxiliary components that ensure shape stability, proper absorption, and a long shelf life. Among them are microcrystalline cellulose, magnesium stearate, croscarmellose sodium, and special film coatings that give the tablet its pink color. These inactive ingredients are hypoallergenic and safe for the vast majority of patients, but their presence should be taken into account by individuals with specific dietary or chemical intolerances. Thanks to the balanced composition, the drug is released evenly in the gastrointestinal tract, ensuring a stable concentration of the active substance in the blood.

The mechanism of action of the active component consists in reducing the level of serotonin, which often acts as an inhibitor of sexual desire, and simultaneously increasing the levels of dopamine and norepinephrine. Dopamine and norepinephrine are neurotransmitters that stimulate sexual arousal and interest in intimacy. Thus, FLIBANSERIN (ADDYI) creates a favorable neurochemical background for the restoration of normal libido. It is important to remember that the effect of taking the drug does not occur instantly, as some time is required to rebuild the neurotransmitter balance.

Dosage of FLIBANSERIN (ADDYI)

The standard recommended dose of FLIBANSERIN (ADDYI) for adult women is 100 milligrams once a day. This dose must be taken strictly at bedtime, which is a critically important rule for safe therapy. Taking the drug at any other time of day significantly increases the risk of developing serious side effects, such as a sharp drop in blood pressure, dizziness, or sudden loss of consciousness. Exceeding the specified dosage is strictly prohibited, as this will not lead to a faster effect, but will significantly increase the toxic load on the body.

The duration of the therapeutic course is determined individually, but the first positive changes are usually observed no earlier than after four weeks of regular use. A full assessment of the treatment's effectiveness is carried out by a doctor after eight weeks of continuous therapy with FLIBANSERIN (ADDYI). If during this time the patient does not notice any improvement in her condition and restoration of sexual desire, the medication should be discontinued. Continuing treatment in case of its ineffectiveness is considered inappropriate and does not justify potential health risks.

Dose adjustment may be necessary for patients with certain concomitant diseases or those taking other medications. In particular, in cases of mild liver function impairment, the doctor may review the treatment regimen, while in severe liver pathologies, the drug is completely contraindicated. Changing the dosage independently, taking breaks in administration, or dividing the tablet into parts is strictly prohibited. Any changes in the therapeutic regimen must occur exclusively under the supervision of a medical specialist after an appropriate examination.

How to take FLIBANSERIN (ADDYI) correctly?

The correct method of taking FLIBANSERIN (ADDYI) involves swallowing the tablet whole, washing it down with a sufficient amount of plain still water. Do not chew, crush, or dissolve the tablet before use, as this may disrupt the release rate of the active substance. Administration is carried out exclusively in the evening, immediately before going to bed. Food does not have a significant effect on the absorption of the drug, so it can be taken both on an empty stomach and after a light dinner.

In case you accidentally miss an evening dose, taking the missed tablet the next morning is strictly prohibited. You should simply wait until the next evening and take the usual dose of FLIBANSERIN (ADDYI) at bedtime according to the standard schedule. Doubling the dose to compensate for a missed one can lead to a dangerous overdose and the development of severe hypotension. Regularity is important for maintaining stable levels of the drug in the blood, but safety always comes first.

During the course of treatment, certain precautions should be observed to minimize the risk of complications. In particular, it is necessary to avoid consuming grapefruit juice, as it contains enzymes that block the breakdown of the active substance in the liver, leading to its accumulation in the body. It is also important to remember the individual reaction of the body, which may manifest as morning drowsiness or sluggishness. Carefully monitor your well-being in the first weeks of therapy and immediately report any alarming symptoms to your doctor.

Side effects of FLIBANSERIN (ADDYI)

Like any powerful pharmacological agent, FLIBANSERIN (ADDYI) can cause a number of side effects of varying intensity. The most common adverse reactions include dizziness, severe drowsiness, nausea, increased fatigue, and dry mouth. These symptoms are usually mild to moderate and often disappear on their own as the body adapts to the treatment. However, if they cause significant discomfort or do not go away over time, it is necessary to consult a medical specialist.

Uncommon but more serious side effects include a significant drop in blood pressure (hypotension) and sudden fainting (syncope). The risk of these conditions increases significantly if the rules for taking the drug are violated, in particular when using it during the daytime or together with alcoholic beverages. Rare adverse reactions may include allergic skin rashes, sleep disturbances in the form of insomnia, or anxiety. If any signs of an allergy occur, such as swelling of the face or difficulty breathing, you should immediately stop taking the medication.

It is necessary to seek emergency medical help in cases where, after taking the tablet, severe dizziness occurs, accompanied by darkening of the eyes or inability to stand. Also, consulting a doctor before administration is a prerequisite for preventing most of these complications. The patient must be informed about all possible risks and know the algorithm of actions in case of deterioration of well-being. Only a responsible attitude to therapy guarantees its safety and high efficiency.

Contraindications of FLIBANSERIN (ADDYI)

The drug FLIBANSERIN (ADDYI) has a clear list of absolute contraindications under which its prescription is categorically unacceptable. Such conditions include any degree of hepatic impairment, as the metabolism of the active substance occurs precisely in the liver, and impairment of its function will lead to toxic accumulation of the drug. Also, an absolute contraindication is the simultaneous use with moderate or strong inhibitors of the CYP3A4 enzyme, which include certain antibiotics and antifungal agents. A history of severe cardiovascular diseases also requires avoiding the use of this medication.

Relative contraindications include a predisposition to hypotension, depressive disorders in the acute stage, and the use of certain sedative drugs. In these cases, the doctor must carefully weigh the potential benefits of the treatment against the possible risks to the patient's health. It is important to consider that FLIBANSERIN (ADDYI) can enhance the effect of drugs that depress the central nervous system. Therefore, full disclosure of information about all the medications you are taking is a critically important step during a medical consultation.

As for special patient groups, the use of the drug during pregnancy and lactation is strictly prohibited due to the lack of reliable data on its safety for the fetus and infant. The drug is not prescribed to children and adolescents under 18 years of age, as its effect on the developing body has not been studied. For elderly postmenopausal women, the use of this agent is also not clinically justified. Always remember the need to consult a doctor before taking any new medications.

Interaction of FLIBANSERIN (ADDYI) with other drugs and alcohol

The drug interaction of FLIBANSERIN (ADDYI) is extremely complex and requires increased attention from medical personnel and the patient. It is prohibited to combine this agent with drugs for the treatment of HIV infection, certain antidepressants, macrolide antibiotics, and drugs for the treatment of hepatitis C. Simultaneous use with these medicines can lead to a critical drop in blood pressure and respiratory arrest. Even over-the-counter supplements, such as St. John's wort, can unpredictably affect the efficacy and safety of therapy with this pharmacological agent.

The compatibility of the drug with alcohol is one of the most important safety issues, as ethyl alcohol repeatedly enhances the depressant effect on the nervous system. Patients are categorically advised to completely avoid alcoholic beverages at least two hours before taking the tablet and to avoid them until the next morning. Due to the risk of severe drowsiness and decreased concentration, after taking FLIBANSERIN (ADDYI), it is prohibited to drive vehicles or work with complex mechanisms for at least six hours.

Where to buy FLIBANSERIN (ADDYI) in Ukraine

You can purchase FLIBANSERIN (ADDYI) in Ukraine in licensed pharmacy chains or through certified online pharmacies that have the right to sell prescription drugs. Since this medication has specific indications and serious risks if used incorrectly, its dispensing is carried out exclusively upon presentation of a properly issued prescription from a doctor. Avoid doubtful internet resources that offer to buy the medicine without a prescription, as the risk of purchasing a dangerous counterfeit is very high.

When ordering online, pay attention to the delivery and storage conditions offered by the pharmacy. The drug should be stored in its original packaging at room temperature, away from direct sunlight and excessive moisture, in a place inaccessible to children. Many modern pharmacies offer convenient courier delivery complying with all temperature regimes, which guarantees the preservation of the pharmacological properties of the medicine. Always check the expiration date and the integrity of the packaging upon receiving your order.